US2017211057A1PendingUtilityA1

Expression Vector Comprising a Polynucleotide Encoding a Modified Glutamine Synthetase and a Method for Preparing a Target Protein Employing the Same

Assignee: ARES TRADING SAPriority: Mar 12, 2012Filed: Jan 5, 2017Published: Jul 27, 2017
Est. expiryMar 12, 2032(~5.6 yrs left)· nominal 20-yr term from priority
C07K 2319/30C12N 9/93C12N 2840/203C07K 14/71C12N 15/85A61K 35/12C12Y 603/01002C12N 15/52C12N 9/00C12N 15/63
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a vector comprising a polynucleotide encoding a modified glutamine synthetase (GS), and a method for preparing a target protein employing the same. More particulary, the present invention relates to a modified GS having an increased sensitivity to a glutamine synthetase (GS) inhibitor, a polynucleotide encoding the modified GS, a vector comprising the polynucleotide, a transformat comprising the vector, and a method for preparing a target protein using the transformat.

Claims

exact text as granted — not AI-modified
1 . A modified glutamine synthetase (GS), wherein glycine (Gly, G) at position 299 of a glutamine synthetase having an amino acid sequence shown in SEQ ID NO. 4 is substituted with arginine (Arg, R). 
     
     
         2 . The modified glutamine synthetase according to  claim 1 , having an increased sensitivity to a glutamine synthetase inhibitor, compared to the glutamine synthetase having an amino acid sequence shown in SEQ ID NO.4. 
     
     
         3 . The modified glutamine synthetase according to  claim 2 , wherein the glutamine synthetase inhibitor is selected from the group consisting of glycine, alanine, tryptophan, histidine, glucosamine-6-phosphate, cytidine triphosphate, methionine sulphoximine (MSX), and combinations thereof. 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . (canceled) 
     
     
         16 . A target protein prepared by a method comprising culturing a transformant comprising a vector for expression of a target protein, comprising the polynucleotide encoding a modified glutamine synthetase wherein glycine (Gly, G) at position 299 of a glutamine synthetase having an amino acid sequence shown in SEQ ID NO. 4 is substituted with arginine (Arg, R).

Join the waitlist — get patent alerts

Track US2017211057A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.